| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |